Exhibit 99.1
NYSE American Notifies General Moly About
Stockholders’ Equity Continued Listing
Deficiency
LAKEWOOD, COLORADO, September 4, 2020 – General Moly,
Inc. (the “Company”) (NYSE American and TSX: GMO), the
only western-exchange listed, pure-play molybdenum mineral
development company, today announced that on August 31, 2020, it
received a deficiency letter (“Letter”) from the NYSE
American stock exchange (the “Exchange”) indicating
that the Company is below compliance with Section 1003(a)(i)
(requiring stockholders’ equity of $2.0 million or more if it
has reported losses from continuing operations and/or net losses in
two of its three most recent fiscal years), Section 1003(a)(ii)
(requiring stockholders’ equity of $4.0 million or more if it
has reported losses from continuing operations and/or net losses in
three of its four most recent fiscal years), and Section
1003(a)(iii) (requiring stockholders’ equity of $6.0 million
or more if it has reported losses from continuing operations and/or
net losses in its five most recent fiscal years) of the NYSE
American Company Guide (the “Company Guide”). The
Exchange indicated that its review showed that the Company reported
a stockholders’ deficit as of June 30, 2020 and losses from
continuing operations for its five most recent fiscal years ended
December 31, 2019.
Accordingly,
the Company must submit to the Exchange, no later than September
30, 2020, a plan of compliance to address how it intends to regain
compliance with Section 1003(a)(i), Section 1003(a)(ii) or Section
1003(a)(iii) of the Company Guide by February 28, 2022. If the
Company does not submit a plan of compliance, or if the plan is not
accepted by the Exchange, the Company’s common stock will be
subject to delisting procedures as set forth in Section 1010 and
Part 12 of the Company Guide. If the plan is accepted by the
Exchange, the Company will be subject to periodic reviews including
quarterly monitoring for compliance with the plan.
If the
Company is not in compliance with the Exchange’s continued
listing standards of Section 1003(a)(i), Section 1003(a)(ii) or
Section 1003(a)(iii) by February 28, 2022, or does not make
progress consistent with the plan during the compliance period, the
Exchange will initiate delisting proceedings.
The
Company has had a conversation with the Exchange regarding whether
and to what extent it can submit a plan of compliance based on
current facts and circumstances. The Company cannot assure that it
will submit a plan or, if it submits a plan, such plan will be
accepted. The Company’s common stock will continue to trade
on the Exchange during the period of non-compliance unless and
until the Exchange delists it. Receipt of the Letter does not
affect the Company’s Securities and Exchange Commission
reporting requirements. The Company has a significant working
capital deficit and there remains substantial doubt about the
Company’s ability to continue as a going concern. If the
Company is unable to find an additional source of funding, it will
be forced to cease operations and pursue restructuring or
liquidation alternatives, including the filing for bankruptcy
protection, in which event the Company’s common stock would
likely become worthless and investors would likely lose their
entire investment in the Company. In addition, holders of the
Company's outstanding convertible preferred stock and senior notes
would likely receive significantly less than the principal amount
of their claims and possibly, no recovery at all. As of the date of
this news release, the Company has no commitments for additional
funding and there can be no assurance that the Company will be
successful in obtaining the financing required to complete the Mt.
Hope Project, or in raising additional financing in the future on
terms acceptable to the Company, or at all.
About General Moly
General
Moly is a U.S.-based, molybdenum mineral exploration and
development company listed on the NYSE American, recently known as
the NYSE MKT and former American Stock Exchange, and the Toronto
Stock Exchange under the symbol GMO. The Company’s primary
asset, an 80% interest in the Mt. Hope Project located in
central Nevada, is considered one of the world’s largest and
highest grade molybdenum deposits. General Moly’s goal is to
become the largest primary molybdenum producer in the
world.
Molybdenum
is a metallic element used primarily as an alloy agent in steel
manufacturing. When added to steel, molybdenum enhances steel
strength, resistance to corrosion and extreme temperature
performance. In the chemical and petrochemical industries,
molybdenum is used in catalysts, especially for cleaner burning
fuels by removing sulfur from liquid fuels, and in corrosion
inhibitors, high performance lubricants and polymers.
Contact:
Scott
Roswell
(303)
928-8591
info@generalmoly.com
Website:
www.generalmoly.com
Forward-Looking Statements
Statements
herein that are not historical facts are “forward-looking
statements” within the meaning of Section 27A of the
Securities Act, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended and are intended to be covered by
the safe harbor created by such sections. Such
forward-looking statements involve a number of risks and
uncertainties that could cause actual results to differ materially
from those projected, anticipated, expected, or implied by the
Company. These risks and uncertainties include, but are not
limited to availability of cash to continue ongoing operations and
the possibility of seeking bankruptcy protection, that COVID-19 is
having and will continue to have an effect on financing efforts to
improve liquidity, availability of insurance, metals price and
production volatility, global economic conditions, currency
fluctuations, increased production costs and variances in ore grade
or recovery rates from those assumed in mining plans, exploration
risks and results, reclamation risks, political, operational and
project development risks, ability to maintain required federal and
state permits to continue construction, and commence production of
molybdenum, copper, silver, lead or zinc, ability to identify any
economic mineral reserves of copper, silver, lead or zinc; ability
of the Company to obtain approval of its joint venture partner at
the Mt. Hope Project in order to mine for molybdenum, copper,
silver, lead or zinc, ability to raise required project financing
or funding to pursue an exploration program related to potential
copper, silver lead or zinc deposits at Mt. Hope, ability to
respond to adverse governmental regulation and judicial outcomes,
and ability to maintain and /or adjust estimates related to cost of
production, capital, operating and exploration expenditures.
For a detailed discussion of risks and other factors that may
impact these forward looking statements, please refer to the Risk
Factors and other discussion contained in the Company's quarterly
and annual periodic reports on Forms 10-Q and 10-K, on file with
the SEC. The Company undertakes no obligation to update
forward-looking statements.